Widely-used medicine recalled due to potentially reduced efficacy
CINCINNATI (WKRC) – A popular and widely-used medicine was recalled because it may not be as effective as…
Scientists question the safety and efficacy of the diet for metabolic health
A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects…
CRATERs identified as key sites for T cell-mediated tumor destruction
Like the surface of the moon, new research published today in Cell finds the existence of craters on…
Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases
Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare…
The neurological complexity of Mamba snake venoms uncovered
A breakthrough study at The University of Queensland has discovered a hidden dangerous feature in the Black Mamba…
Controversy surrounding Covid-19 vaccination during pregnancy
Whether or not those who are pregnant should take a Covid-19 vaccine to protect themselves and their infants…
Hypnosis improves patient comfort and outcomes for acute respiratory failure
Hypnosis can significantly improve patients’ tolerance of masks to help them breathe when they are suffering from acute…
Precision probiotics lower blood sugar and cholesterol in mice
A new mouse study reveals that carefully selected probiotics can lower blood sugar, body fat, and cholesterol levels…
Brain shunt surgery improves walking and quality of life in older adults with hydrocephalus
Implanting a brain shunt in older people diagnosed with idiopathic normal pressure hydrocephalus (iNPH) is effective in improving…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…